Citation only
via OpenAlex
Prolonged absence of myostatin reduces sarcopenia
Victoria Siriett, Leanne Platt, Mônica Senna Salerno, Nicholas Ling, Ravi Kambadur, Mridula Sharma
Journal of Cellular Physiology · 2006 · ▲ 140 citations
Abstract
Sarcopenia is a progressive age-related loss of skeletal muscle mass and strength. Parabiotic experiments show that circulating factors positively influence the proliferation and regenerative capacity of satellite cells in aged mice. In addition, we believe that negative regulators of muscle mass also serve to balance the signals that influence satellite cell activation and regeneration capacity with ageing. Myostatin, a negative regulator of pre- and postnatal myogenesis, inhibits satellite cell activation and muscle regeneration postnatally. To investigate the role of myostatin during age-related sarcopenia, we examined muscle mass and regeneration in young and old myostatin-null mice. Young myostatin-null muscle fibers were characterized by massive hypertrophy and hyperplasia and an increase in type IIB fibers, resulting in a more glycolytic muscle. With ageing, wild-type muscle became increasingly oxidative and fiber atrophy was prominent. In contrast no fiber type switching was observed and atrophy was minimal in aged myostatin-null muscle. The effect of ageing on satellite cell numbers appeared minimal, however, satellite cell activation declined significantly in both wild-type and myostatin-null muscles. In young mice, lack of myostatin resulted in increased satellite cell number and activation compared to wild-type, suggesting a greater propensity to undergo myogenesis, a difference maintained in the aged mice. In addition, muscle regeneration of myostatin-null muscle following notexin injury was accelerated and fiber hypertrophy and type were recovered with regeneration, unlike in wild-type muscle. In conclusion, a lack of myostatin appears to reduce age-related sarcopenia and loss of muscle regenerative capacity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/jcp.20778
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Siriett, V., Platt, L., Salerno, M.S., Ling, N., Kambadur, R., & Sharma, M. (2006). Prolonged absence of myostatin reduces sarcopenia. <em>Journal of Cellular Physiology</em>. https://doi.org/10.1002/jcp.20778
Vancouver
Siriett V, Platt L, Salerno MS, Ling N, Kambadur R, Sharma M. Prolonged absence of myostatin reduces sarcopenia. Journal of Cellular Physiology. 2006. doi:10.1002/jcp.20778.
BibTeX
@article{victoria2006Prolon,
title = {Prolonged absence of myostatin reduces sarcopenia},
author = {Victoria Siriett and Leanne Platt and Mônica Senna Salerno and Nicholas Ling and Ravi Kambadur and Mridula Sharma},
journal = {Journal of Cellular Physiology},
year = {2006},
doi = {10.1002/jcp.20778},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Therapy 2007
Open access · CC-BY
Antagonism of Myostatin Enhances Muscle Regeneration During Sarcopenia
The FASEB Journal 2013
Citation only
Sarcopenia and hypertrophy in aged skeletal muscle is independent of lifelong muscle stem cell depletion
Proceedings of the National Academy of Sciences 2009
Preprint · CC-BY
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity
Journal of Clinical Investigation 2012
Open access · OA
microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice
Elsevier eBooks 2008
Citation only
Age-Related Bone Loss and Osteoporosis
Elsevier eBooks 2020
Citation only